Over 1,500 stocks received institutional research in November, with Luxshare Precision Industry Co., Ltd. attracting the highest number of institutional visits.
Luxshare Precision was surveyed by 576 institutions, including 148 fund companies, 85 securities firms, 65 private equity firms, and 38 insurance companies.
During a recent investor meeting, Luxshare Precision (002475) stated that it remains challenging for a fully independent AI terminal to replace smartphones in the foreseeable future. The company's strategy involves closely monitoring domestic and international enterprises with strong AI models and ecosystem capabilities, seeking deep collaboration with such high-potential partners. Currently, Luxshare has made solid progress in this area. From a product perspective, the company believes AI-powered audio and visual devices, such as smart glasses and earphones, are most likely to achieve a market scale of tens of millions.
As a Chinese company with tens of thousands of employees, Luxshare noted that about 90% of its products serve overseas clients, while roughly two-thirds of its production capacity remains in China. The company collaborates closely with customers to optimize existing capacity by analyzing regional production efficiency requirements, avoiding cost increases from relocation.
Regarding robotics, Luxshare disclosed an annual shipment target of 3,000 units but emphasized that volume is not the current priority, as mass-producible robots have yet to emerge. Instead, the company focuses on partnering with key industry players to ensure its core components contribute to final product standards and enhance manufacturing efficiency in industrial robotics.
Other stocks, including Inovance Technology, Imeik Technology, Supcon Technology, and Montage Technology, also drew over 100 institutional surveys. Inovance revealed that it showcased humanoid robot components at the China International Industry Fair in late September 2025, featuring products like 7-DOF bionic arms, planetary joint actuators, and frameless torque motors.
Notably, Inovance’s survey included 103 overseas institutions and 11 QFIIs, such as Temasek’s Fullerton, Amber Capital, and Morgan Stanley. Luxshare, Opt Machine Vision, Orbbec, BeiGene, and Montage Technology also garnered significant foreign investor interest.
In terms of market performance, stocks surveyed by institutions fell over 1% on average in November. However, Binhai Energy, Mengtian Home, Dazhong Mining, and Fuxiang Pharma surged more than 50%.
Dazhong Mining highlighted the advantages of its Sichuan Jiada lithium mine, noting its high-grade spodumene ore, substantial reserve expansion potential, and scalable production. The company’s self-operated mining team enables refined cost control. Its Hunan Jijiaoshan lepidolite mine benefits from integrated mining-processing-smelting operations, allowing flexible adjustments to concentrate grade and recovery rates. A proprietary sulfuric acid lithium extraction process boosts recovery rates while recycling potassium and meeting strict environmental standards.
Fuxiang Pharma plans to expand its VC production capacity to 10,000 tons/year through upgrades, with completion expected by Q2 2026.
Heshun Petroleum stated that management is actively pursuing transformation, citing Kuixin Tech’s leading position in high-speed interface IP products and the semiconductor IP industry’s growth potential. Favorable macroeconomic conditions and supportive policies further facilitate this cross-sector acquisition.
Comments